Skip to main content

Table 1 Clinical characteristics of the participants to the population-based Australian Breast Cancer Family Registry that were genotyped for RNASEL:p.Glu265*

From: Is RNASEL:p.Glu265* a modifier of early-onset breast cancer risk for carriers of high-risk mutations?

 

Cases (n = 1445)

Controls (n = 827)

Age at diagnosis (years)

42 [23–59]

n/a

Age at recruitment (years)

43 [23–60]

41 [20–60]

Ethnicity

 White/Caucasian

1345 (93%)

710 (85.9%)

 Asian and Pacific Islander

85 (5.9%)

32 (3.9%)

 Other

8 (0.6%)

7 (0.8%)

 Unknown

7 (0.5%)

78 (9.4%)

Laterality

 Right breast

713 (49.3%)

n/a

 Left breast

732 (50.7%)

n/a

Estrogen Receptor Status

 Negative

439 (30.4%)

n/a

 Positive

815 (56.4%)

n/a

 Unknown

191 (13.2%)

n/a

Grade

 GI

212 (14.6%)

n/a

 GII

526 (36.4%)

n/a

 GIII

555 (38.4%)

n/a

 GIV

3 (0.2%)

n/a

 Unknown

149 (10.4%)

n/a

  1. n/a: not applicable
  2. GI, grade I; GII, grade II; GIII, Grade III; GIV, Grade IV